Rilmazafone — CAS 196597-26-9

Rilmazafone is a high-purity Active Pharmaceutical Ingredient (API) classified as a Benzodiazepine prodrug with Sedative-Hypnotic properties. Mediocon Inc manufactures GMP-compliant Rilmazafone at its facility in Aurangabad, Maharashtra, India.

• Short-term treatment of insomnia
• Pre-operative sedation
• Anxiety and tension management
• Benzodiazepine receptor modulation research

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support